CASE STUDY

Case Study: Target discovery for rheumatoid arthritis

Learn more about Euretos computational disease model and how it predicts many of the known drug targets for RA.

In this case study you will learn about:

  • How Euretos has contributed to real world results for five different biopharma clients, including approved drugs and active clinical trials in oncology, Sjogren’s disease, Ulcerative Colitis, NASH and epilepsy.
  • Our computational disease model and how it predicts many of the known drug targets for rheumatoid arthritis.
  • How we predict over 200 novel targets for RA that have high scores and are prime candidates to consider.

Register your details to find out more.